ZS Pharma, Inc. Operating Income
ZS Pharma, Inc. reported Operating Income of -$35.25 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2015-11-09
- ZS Pharma, Inc. operating income (loss) for the quarter ending 2015-09-30 was -$35.25M.
- ZS Pharma, Inc. operating income (loss) for the quarter ending 2015-06-30 was -$32.45M.
- ZS Pharma, Inc. operating income (loss) for the quarter ending 2015-03-31 was -$21.72M.
- ZS Pharma, Inc. operating income (loss) for the quarter ending 2014-12-31 was -$20.11M.
- ZS Pharma, Inc. operating income (loss) for fiscal 2014 was -$60.54M.
- ZS Pharma, Inc. operating income (loss) for fiscal 2013 was -$32.19M.
- ZS Pharma, Inc. operating income (loss) for fiscal 2012 was -$8.14M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$35.25M 10-Q · filed 2015-11-09 | -$67.70M derived: sum of 2 quarters · filed 2015-11-09 | -$89.42M 10-Q · filed 2015-11-09 | -$109.53M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | -$32.45M 10-Q · filed 2015-08-06 | -$54.17M 10-Q · filed 2015-08-06 | -$74.28M derived: sum of 3 quarters · filed 2015-08-06 | -$90.91M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | -$21.72M 10-Q · filed 2015-05-11 | -$41.83M derived: sum of 2 quarters · filed 2015-05-11 | -$58.45M derived: sum of 3 quarters · filed 2015-11-09 | -$72.98M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | -$20.11M 10-K · filed 2015-03-13 | -$36.73M derived: sum of 2 quarters · filed 2015-11-09 | -$51.26M derived: sum of 3 quarters · filed 2015-11-09 | -$60.54M 10-K · filed 2015-03-13 |
| 2014-09-30 | -$16.62M 10-Q · filed 2015-11-09 | -$31.15M derived: sum of 2 quarters · filed 2015-11-09 | -$40.43M 10-Q · filed 2015-11-09 | -$50.83M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | -$14.53M 10-Q · filed 2015-08-06 | -$23.81M 10-Q · filed 2015-08-06 | -$34.21M derived: sum of 3 quarters · filed 2015-08-06 | -$43.57M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | -$9.28M 10-Q · filed 2015-05-11 | -$19.68M derived: sum of 2 quarters · filed 2015-05-11 | -$29.04M derived: sum of 3 quarters · filed 2015-05-11 | -$36.35M derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | -$10.40M 10-K · filed 2015-03-13 | -$19.76M derived: sum of 2 quarters · filed 2015-03-13 | -$27.07M derived: sum of 3 quarters · filed 2015-03-13 | -$32.19M 10-K · filed 2015-03-13 |
| 2013-09-30 | -$9.36M 10-K · filed 2015-03-13 | -$16.67M derived: sum of 2 quarters · filed 2015-03-13 | -$21.79M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$7.31M 10-K · filed 2015-03-13 | -$12.43M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$5.12M 10-K · filed 2015-03-13 | |||
| 2012-12-31 | -$8.14M 10-K · filed 2015-03-13 |